Cardiac Rhythm Management Devices | Market Insights | US | 2023
The COVID-19 global pandemic has had a significant impact on the US CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery, the market will grow slightly through 2031. Revenue growth will be driven by rising ICM and pulse generator envelope procedure volumes and the adoption of premium-priced innovative products, such as leadless pacemakers and S-ICDs, but this will be largely offset by relatively flat pulse generator sales and price erosion.
This Medtech 360 Report provides comprehensive data and analysis on the state of the US cardiac rhythm management device market from 2019 through 2031.